These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 36286020)

  • 1. Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer.
    Cao M; Wang Y; Lu G; Qi H; Li P; Dai X; Lu J
    Curr Issues Mol Biol; 2022 Sep; 44(10):4447-4471. PubMed ID: 36286020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells.
    Silva VR; Santos LS; Dias RB; Quadros CA; Bezerra DP
    Cancer Commun (Lond); 2021 Dec; 41(12):1275-1313. PubMed ID: 34791817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis-Related Functions of Wnt Signaling in Colorectal Carcinogenesis.
    Kasprzak A
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33276489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short interfering RNA in colorectal cancer: is it wise to shoot the messenger?
    Chandramohan K; Balan DJ; Devi KP; Nabavi SF; Reshadat S; Khayatkashani M; Mahmoodifar S; Filosa R; Amirkhalili N; Pishvaei S; Sargazi-Aval O; Nabavi SM
    Eur J Pharmacol; 2023 Jun; 949():175699. PubMed ID: 37011722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs and JAK/STAT signaling pathway regulation in colorectal cancer development.
    Ghasemian A; Omear HA; Mansoori Y; Mansouri P; Deng X; Darbeheshti F; Zarenezhad E; Kohansal M; Pezeshki B; Wang Z; Tang H
    Front Genet; 2023; 14():1297093. PubMed ID: 38094755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways.
    Ibrahim SSA; Salama MA; Selima E; Shehata RR
    Life Sci; 2020 Nov; 260():118261. PubMed ID: 32795539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
    Zhu Z; Hou Q; Guo H
    Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib.
    Papadimitriou M; Papadimitriou CA
    Anticancer Res; 2021 Feb; 41(2):567-582. PubMed ID: 33517262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements.
    Malki A; ElRuz RA; Gupta I; Allouch A; Vranic S; Al Moustafa AE
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer.
    Rajitha B; Nagaraju GP; Shaib WL; Alese OB; Snyder JP; Shoji M; Pattnaik S; Alam A; El-Rayes BF
    Mol Carcinog; 2017 Jan; 56(1):288-299. PubMed ID: 27128654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4'-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling.
    Sun D; Zhang F; Qian J; Shen W; Fan H; Tan J; Li L; Xu C; Yang Y; Cheng H
    Chem Biol Interact; 2018 Dec; 296():26-33. PubMed ID: 30217479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer.
    Ding X; Qiu L; Zhang L; Xi J; Li D; Huang X; Zhao Y; Wang X; Sun Q
    Onco Targets Ther; 2016; 9():1189-204. PubMed ID: 27022279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of
    Jiao HL; Ye YP; Yang RW; Sun HY; Wang SY; Wang YX; Xiao ZY; He LQ; Cai JJ; Wei WT; Chen YR; Gu CC; Cai YL; Hu YT; Lai QH; Qiu JF; Liang L; Cao GW; Liao WT; Ding YQ
    Clin Cancer Res; 2017 Nov; 23(22):7108-7118. PubMed ID: 28912140
    [No Abstract]   [Full Text] [Related]  

  • 17. The Stemness-High Human Colorectal Cancer Cells Promote Angiogenesis by Producing Higher Amounts of Angiogenic Cytokines via Activation of the Egfr/Akt/Nf-κB Pathway.
    Chung SY; Chao TC; Su Y
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells.
    Miyazaki T; Taketomi Y; Saito Y; Hosono T; Lei XF; Kim-Kaneyama JR; Arata S; Takahashi H; Murakami M; Miyazaki A
    Circ Res; 2015 Mar; 116(7):1170-81. PubMed ID: 25648699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in cancer - general pathways and their therapeutic implications.
    Dimova I; Popivanov G; Djonov V
    J BUON; 2014; 19(1):15-21. PubMed ID: 24659637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sesamin inhibits hypoxia-stimulated angiogenesis
    Huang Y; Liu Z; Li L; Jiang M; Tang Y; Zhou L; Li J; Chen Y
    Food Funct; 2022 Aug; 13(17):8989-8997. PubMed ID: 35939045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.